Project PrEPare – an Open Label Demonstration Project and Phase II Safety Study of Pre-exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM) in the United States

This pre-exposure prophylaxis (PrEP) demonstration project and phase II safety study aimed to obtain additional data on the safety of emtricitabine/tenofovir (FTC/TDF (Truvada�)). Patterns of use, rates of adherence, and patterns of sexual risk behavior among YMSM (inclusive of transgender women) who were provided with open label FTC/TDF (Truvada�) and information on the safety and efficacy of PrEP from prior studies were evaluated. Furthermore, this project explored the feasibility and acceptability of implementing two different types of efficacious risk reduction interventions prior to the provision of PrEP – Many Men, Many Voices (3MV) and Personalized Cognitive Counseling (PCC).